Epigenetic genome-wide association methylation in aging and longevity
- PMID: 23130832
- PMCID: PMC4123813
- DOI: 10.2217/epi.12.41
Epigenetic genome-wide association methylation in aging and longevity
Abstract
The aging phenotype is the result of a complex interaction between genetic, epigenetic and environmental factors. Evidence suggests that epigenetic changes (i.e., a set of reversible, heritable changes in gene function or other cell phenotype that occurs without a change in DNA sequence) may affect the aging process and may be one of the central mechanisms by which aging predisposes to many age-related diseases. The total number of altered methylation sites increases with increasing age, such that they could serve as marker for chronological age. This article systematically highlights the advances made in the field of epigenomics and their contribution to the understanding of the complex physiology of aging, lifespan and age-associated diseases.
References
-
- World Health Statistics Annual 1996. Geneva, Switzerland: WHO; 1998.
-
- From the Centers for Disease Control and Prevention. Public health and aging: trends in aging – United States and worldwide. JAMA. 2003;289(11):1371–1373. - PubMed
-
- Porcu M, Chiarugi A. The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension. Trends Pharmacol. Sci. 2005;26(2):94–103. - PubMed
-
- Ventura A, Luzi L, Pacini S, Baldari CT, Pelicci PG. The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter. J. Biol. Chem. 2002;277(25):22370–22376. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical